Skin permeation study of dehydroepiandrosterone (DHEA) compared with its α-cyclodextrin complex form

Journal of Pharmaceutical Sciences

Volumn 91, Issue 11, 2002, Pages 2399-2407

  Ceschel, Gian Carlo ^a   Mora, Paolo Corvi ^b   Borgia, Simone Lombardi ^a   Maffei, Paola ^a   Ronchi, Celestino ^c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Euphar Group Srl   (Italy)

^c MonteResearch SrI   (Italy)

Author keywords

Cyclodextrin; Dehydroepiandrosterone; Skin permeation

Indexed keywords

ALPHA CYCLODEXTRIN; GLYCINE; HYDROXYPROPYLMETHYLCELLULOSE; PRASTERONE; WATER;

ANIMAL TISSUE; AQUEOUS SOLUTION; ARTICLE; COMPLEX FORMATION; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; GEL; IN VITRO STUDY; NONHUMAN; PARTITION COEFFICIENT; SKIN PERMEABILITY; SUSPENSION; SWINE;

EID: 0036828059     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1002/jps.10229     Document Type: Article

References (32)

1. Orentreich N, Brind JL, Rizer RL, Vogelman JH. 1984. Age changes and sex differences in serum dehydroepiandrosterone sulfate concentration throughout adulthood. J Clin Endocr Metab 59:551-555.
2. Khaw KT. 1996. Dehydroepiandrosterone, dehydroepiandrosterone sulphate and cardiovascular disease. J Endocrinol 150:149-153.
3. Regelson W, Kalimi M. 1994. Dehydroepiandrosterone (DHEA) - The multifunctional steroid - Effects on the CNS, cell proliferation, metabolic and vascular, clinical and other effects. Mechanism of action? Ann NY Acad Sci 719:564-575.
4. Barrou Z, Charru P, Lidy C. 1997. Dehydroepiandrosterone (DHEA) and aging. Arch Gerontol Geriat 24:233-241.
5. Casson PR, Carson SA, Buster JE. 1998. Replacement of dehydroepiandrosterone in the elderly: Rationale and prospects for the future. Endocrinologist 8:187-194.
6. Laneri S, Sacchi A, Abignente di Frassello P, Luraschi E, Colombo P, Santi P. 1999. Ionized prodrugs of dehydroepiandrosterone for transdermal iontophoretic delivery. Pharm Res 16:1818-1824.
7. Minghetti P, Cilurzo F, Casiraghi A, Montanari L, Santoro A. 2001. Development of patches for the controlled release of dehydroepiandrosterone. Drug Dev Ind Pharm 27:711-717.
8. McCormack B, Gregoriadis G. 1994. Drugs-incyclodextrins-in-liposomes: A novel concept in drug delivery. Int J Pharm 112:249-258.
9. McCormack B, Gregoriadis G. 1998. Drugs-incyclodextrins-in-liposomes: An approach to controlling the fate of water insoluble drugs in vivo. Int J Pharm 162:59-69.
10. International patent. International application number: PCT/EP99/100100. International publication number: WO 00/37109. Clathrates of dehydroepiandrosterone and corresponding pharmaceutical compositions.
11. Tenjarla S, Puranajoti P, Kasina R, Mandal T. 1998. Preparation, characterisation, and evaluation of miconazole-cyclodextrin complexes for improved oral and topical delivery. J Pharm Sci 87:425-429.
12. Irie T, Uekama K. 1997. Pharmaceutical application of cyclodextrins. III. Toxicological issues and safety evaluation. J Pharm Sci 86:147-162.
13. Legendre JY, Raoult I, Petit A, Luijten W, Demuynck I, Horvath S, Ginot YM, Cuine A. 1995. Effect of β-cyclodextrin on skin: Implication for the transdermal delivery of piribedil and a novel cognition enhancing-drug, S-9977. Eur J Pharm Sci 3:311-322.
14. Loftsson T, Màsson M, Sigurdsson HH, Magnùsson P, Le Goffic F. 1998. Cyclodextrins as co-enhancers in dermal and transdermal drug delivery. Pharmazie 53:137-139.
15. Loftsson T, Masson M. 2001. Cyclodextrins in topical drug formulation: Theory and practice. Int J Pharm 225:15-30.
16. Uekama K, Hirayama F, Irie T. 1998. Cyclodextrin drug carrier systems. Chem Rev 98:2045-2076.
17. Loftsson T. 1998. Increasing the cyclodextrin complexation of drugs and drug bioavalability through addition of water-soluble polymers. Pharmazie 53:733-740.
18. Loftsson T, Fridriksdòttir H, Gudmundsdòttir TK. 1996. The effect of water-soluble polymers on aqueous solubility of drugs. Int J Pharm 127:293-296.
19. Gonzalo-Lumbreras R, Izquierdo-Hornillos R. 2000. Optimisation of high-performance liquid chromatographic separation of a complex mixture containing urinary steroids, boldenone and bolasterone: Application to urine samples. J Chromatogr B 742:47-57.
20. Hatanaka T, Inuma M, Sugibayashi K, Morimoto Y. 1990. Prediction of skin permeability of drugs. I. Comparison with artificial membrane. Chem Pharm Bull 38:3452-3459.
21. Poulin P, Krishnan K. 2001. Molecular structure-based prediction of human abdominal skin permeability coefficients for several organic compounds. J Toxicol Env Health A 62:143-159.
22. Franz TG. 1975. Percutaneous absorption. On the relevance of in vitro data. J Invest Dermatol 64:190-196.
23. Friend DR. 1992. In vitro permeation techniques. J Controlled Release 18:235-248.
24. Bronaugh RL, Maibach HI. 1991. In Vitro Percutaneous Absorption: Principles, Fundamentals and Aplication, Williams DF, editor. Boca Raton, FL: CRC Press.
25. Shah VP, Elkins J, Hanus J, Noorizadeh C, Skelly J. 1991. In vitro release of Hydrocortisone from topical preparations and automated procedure. Pharm Res 8:55-59.
26. Ports RO, Golden GM, Francoeur ML, Mak VHW, Guy RH. 1991. Mechanism and enhancement of solute transport across the stratum corneum. J Controlled Release 15:249-260.
27. Walker M, Hulme TA, Rippon MG, Walmsley RS, Gunnigle S, Lewin M, Winsey S. 1997. In vitro models for the percutaneous delivery of active tissue repair agents. J Pharm Sci 86:1379-1384.
28. Wester RC, Melendres J, Sedik L, Maibach H, Riviere JE. 1998. Percutaneous absorption of salicylic acid, theophylline, 2,4-dimethylamine, diethyl hexyl phthalic acid, and p-aminobenzoic acid in the isolated perfused porcine skin flap compared to man in vivo. Toxicol Appl Pharm 151:159-165
29. Ceschel GC, Maffei P, Gentile M. 1999. Design and evaluation of a new transdermal formulation containing Chlorpheniramine maleate. Drug Dev Ind Pharm 25:1035-1040.
30. Orienti I, Zecchi V, Bertasi V, Fini A. 1991. Release of ketoprofen from dermal bases in presence of cyclodextrins: Effect of the affinity constant determined in semisolid vehicles. Arch Pharm 324:943-947.
31. Sinclair GW, Peppas NA. 1984. Analysis of non-fickian transport polymers using simplified exponential expressions. J Membrane Sci 17:329-331.
32. Màsson M, Loftsson T, Màsson G, Stefànsson E. 1999. Cyclodextrins as permeation enhancers: Some theoretical evaluations and in vitro testing. J Controlled Release 59:107-118.